Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

121
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
121
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

278
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
278
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

188
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality.

Journal of clinical medicine·2025
Same author

Contralateral pelvic lymph node metastases in patients with unilateral early-stage epithelial ovarian cancer: a systematic review and meta-analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women.

Pharmaceutics·2025
Same author

GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives.

International journal of molecular sciences·2025
Same author

Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review.

Journal of diabetes research·2024
Same author

Two-stage surgical intervention for a rare case of intersected nasoethmoidal encephalocele and open-lip schizencephaly in an infant: illustrative case.

Journal of neurosurgery. Case lessons·2024

Related Experiment Video

Updated: Jul 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Making Sense of Composite Endpoints in Clinical Research.

Daniela Baracaldo-Santamaría1, John Edwin Feliciano-Alfonso2, Raul Ramirez-Grueso1

  • 1Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.

Journal of Clinical Medicine
|July 14, 2023
PubMed
Summary

Composite endpoints streamline clinical trials by reducing costs and sample sizes. However, careful interpretation is crucial to avoid misleading conclusions and ensure patient safety.

Keywords:
data interpretationendpoint determinationoutcome assessmentrandomized controlled trialstreatment outcome

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K
Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites
07:04

Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites

Published on: November 9, 2014

13.7K

Related Experiment Videos

Last Updated: Jul 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K
Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites
07:04

Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites

Published on: November 9, 2014

13.7K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacoeconomics

Background:

  • Composite endpoints are frequently used in clinical trials for drug approval.
  • They offer advantages like reduced sample size, shorter follow-up, and lower costs.
  • However, their interpretation can be complex and prone to misuse.

Purpose of the Study:

  • To highlight the challenges in interpreting composite endpoints.
  • To provide guidance on the appropriate use and interpretation of composite endpoints.
  • To inform healthcare professionals and regulatory agencies on best practices.

Main Methods:

  • Review of principles for interpreting composite endpoints in clinical research.
  • Discussion of key questions to assess the validity and interpretability of composite endpoints.
  • Consideration of regulatory agency perspectives on composite endpoints.

Main Results:

  • Composite endpoints are valuable but require careful evaluation of component importance, frequency, and relative risk reduction.
  • Misinterpretation can lead to flawed conclusions impacting patient care.
  • Regulatory agencies have specific criteria for approving drugs based on composite endpoints.

Conclusions:

  • Composite endpoints are essential tools for assessing intervention efficacy and net clinical benefit.
  • Cautious and critical interpretation is advised to ensure accurate clinical decision-making.
  • Understanding the nuances of composite endpoints is vital for evidence-based medicine.